Recent rodent models for Alzheimer's disease: Clinical implications and basic research

Nady Braidy, Pablo Muñoz, Adrian G. Palacios, Gloria Castellano-Gonzalez, Nibaldo C. Inestrosa, Roger S. Chung, Perminder Sachdev, Gilles J. Guillemin*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

93 Citations (Scopus)


Alzheimer's disease (AD) is the most common origin of dementia in the elderly. Although the cause of AD remains unknown, several factors have been identified that appear to play a critical role in the development of this debilitating disorder. In particular, amyloid precursor protein (APP), tau hyperphosphorylation, and the secretase enzymes, have become the focal point of recent research. Over the last two decades, several transgenic and non-transgenic animal models have been developed to elucidate the mechanistic aspects of AD and to validate potential therapeutic targets. Transgenic rodent models over-expressing human β-amyloid precursor protein (β-APP) and mutant forms of tau have become precious tools to study and understand the pathogenesis of AD at the molecular, cellular and behavioural levels, and to test new therapeutic agents. Nevertheless, none of the transgenic models of AD recapitulate fully all of the pathological features of the disease. Octodon degu, a South American rodent has been recently found to spontaneously develop neuropathological signs of AD in old age. This review aims to address the limitations and clinical relevance of transgenic rodent models in AD, and to highlight the potential for O. degu as a natural model for the study of AD neuropathology.

Original languageEnglish
Pages (from-to)173-195
Number of pages23
JournalJournal of Neural Transmission
Issue number2
Publication statusPublished - Feb 2012
Externally publishedYes


Dive into the research topics of 'Recent rodent models for Alzheimer's disease: Clinical implications and basic research'. Together they form a unique fingerprint.

Cite this